TMEM97 and neoplasm: Moreover, the putative overlapping of the pharmacological activity and ligand binding profile of S2R with TMEM97, a protein overexpressed in some tumor types, reinforces the idea that this SR subtype could be a marker for tumorigenesis (Alon et al., 2017).